Zhejiang Hisoar Pharmaceutical Co.,Ltd.’s Net Profit Rose 52.2% in First Quarter of 2022

Zhejiang Hisoar Pharmaceutical Co.,Ltd. (浙江海翔药业股份有限公司) (002099.SZ) reported a net profit of 86.5 million yuan in the first quarter of 2022, up 52.2% year-on-year.

Meanwhile, the company posted 804.5 million yuan in revenue, up 25.3% year-on-year.

At the end of the reporting period, it had 8 billion yuan in total assets and 1.8 billion yuan in total liabilities, with a liability-to-asset ratio of 22.2%.